{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T23:49:55Z","timestamp":1767916195274,"version":"3.49.0"},"reference-count":25,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2020,5,1]],"date-time":"2020-05-01T00:00:00Z","timestamp":1588291200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,5,1]],"date-time":"2020-05-01T00:00:00Z","timestamp":1588291200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","clinical-lung-cancer.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Lung Cancer"],"published-print":{"date-parts":[[2020,5]]},"DOI":"10.1016\/j.cllc.2019.08.004","type":"journal-article","created":{"date-parts":[[2019,10,8]],"date-time":"2019-10-08T18:26:44Z","timestamp":1570559204000},"page":"225-231","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["CT Volumetry and Basic Texture Analysis as Surrogate Markers in Advanced Non\u2013small-cell Lung Cancer"],"prefix":"10.1016","volume":"21","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2069-6458","authenticated-orcid":false,"given":"Benjamin","family":"Owen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Gandara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karen","family":"Kelly","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elizabeth","family":"Moore","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Shelton","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Friedrich","family":"Knollmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.cllc.2019.08.004_bib1","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.ejca.2008.10.026","article-title":"New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1)","volume":"45","author":"Eisenhauer","year":"2009","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.cllc.2019.08.004_bib2","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.acra.2013.09.020","article-title":"Comparison of 1D, 2D, and 3D nodule sizing methods by radiologists for spherical and complex nodules on thoracic CT phantom images","volume":"21","author":"Petrick","year":"2014","journal-title":"Acad Radiol"},{"key":"10.1016\/j.cllc.2019.08.004_bib3","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1016\/j.crad.2014.03.020","article-title":"Revisiting the relationship between tumour volume and diameter in advanced NSCLC patients: an exercise to maximize the utility of each measure to assess response to therapy","volume":"69","author":"Nishino","year":"2014","journal-title":"Clin Radiol"},{"key":"10.1016\/j.cllc.2019.08.004_bib4","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1148\/radiol.2018172319","article-title":"Computer-aided volumetry of part-solid lung cancers by using CT: solid component size predicts prognosis","volume":"287","author":"Kamiya","year":"2018","journal-title":"Radiology"},{"key":"10.1016\/j.cllc.2019.08.004_bib5","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1097\/JTO.0b013e318294c909","article-title":"Tumor volume decrease at 8 weeks is associated with longer survival in EGFR-mutant advanced non-small-cell lung cancer patients treated with EGFR TKI","volume":"8","author":"Nishino","year":"2013","journal-title":"J\u00a0Thorac Oncol"},{"key":"10.1016\/j.cllc.2019.08.004_bib6","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1200\/JCO.2007.13.0344","article-title":"Disease control rate at 8 weeks predicts clinical benefit in advanced non-small-cell lung cancer: results from Southwest Oncology Group randomized trials","volume":"26","author":"Lara","year":"2008","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.cllc.2019.08.004_bib7","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.cllc.2015.09.003","article-title":"Disease control rate at 8 weeks predicts subsequent survival in platinum-treated extensive stage small cell lung cancer: results from the Southwest Oncology Group (SWOG) database","volume":"17","author":"Lara","year":"2016","journal-title":"Clin Lung Cancer"},{"key":"10.1016\/j.cllc.2019.08.004_bib8","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1148\/radiol.2016151301","article-title":"Three-dimensional radiologic assessment of chemotherapy response in Ewing sarcoma can be used to predict clinical outcome","volume":"280","author":"Aghighi","year":"2016","journal-title":"Radiology"},{"key":"10.1016\/j.cllc.2019.08.004_bib9","first-page":"770","article-title":"Measurement of tumor \u201csize\u201d in recurrent malignant glioma: 1D, 2D, or 3D?","volume":"26","author":"Dempsey","year":"2005","journal-title":"Am J Neuroradiol"},{"key":"10.1016\/j.cllc.2019.08.004_bib10","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1007\/s00330-016-4430-3","article-title":"Diffusion-weighted magnetic resonance imaging predicts survival in patients with liver-predominant metastatic colorectal\u00a0cancer shortly after selective internal radiation therapy","volume":"27","author":"Schmeel","year":"2017","journal-title":"Eur Radiol"},{"key":"10.1016\/j.cllc.2019.08.004_bib11","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.cllc.2013.11.001","article-title":"Assessing response to treatment in non-small-cell lung cancer: role of tumor volume evaluated by computed tomography","volume":"15","author":"Knollmann","year":"2014","journal-title":"Clin Lung Cancer"},{"key":"10.1016\/j.cllc.2019.08.004_bib12","doi-asserted-by":"crossref","first-page":"29","DOI":"10.2307\/2530286","article-title":"A\u00a0confidence interval for the median survival time","volume":"38","author":"Brookmeyer","year":"1982","journal-title":"Biometrics"},{"key":"10.1016\/j.cllc.2019.08.004_bib13","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1148\/radiol.2252011604","article-title":"CT tumor measurement for therapeutic response assessment: comparison of unidimensional, bidimensional, and volumetric techniques\u2014initial observations","volume":"225","author":"Prasad","year":"2002","journal-title":"Radiology"},{"key":"10.1016\/j.cllc.2019.08.004_bib14","doi-asserted-by":"crossref","first-page":"e361","DOI":"10.1016\/j.cllc.2018.01.005","article-title":"Best response according to RECIST during first-line EGFR-TKI treatment predicts survival in EGFR-mutation-positive non\u2013small-cell lung cancer patients","volume":"19","author":"Wu","year":"2018","journal-title":"Clin Lung Cancer"},{"key":"10.1016\/j.cllc.2019.08.004_bib15","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1102\/1470-7330.2012.0046","article-title":"Assessing the effect of CT slice interval on unidimensional, bidimensional and volumetric measurements of solid tumours","volume":"12","author":"Tan","year":"2012","journal-title":"Cancer Imaging"},{"key":"10.1016\/j.cllc.2019.08.004_bib16","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.chest.2016.10.010","article-title":"The eighth edition lung cancer stage classification","volume":"151","author":"Detterbeck","year":"2017","journal-title":"Chest"},{"key":"10.1016\/j.cllc.2019.08.004_bib17","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1002\/cncr.24060","article-title":"Early changes in tumor size in patients treated for advanced stage nonsmall cell lung cancer do not correlate with survival","volume":"115","author":"Birchard","year":"2009","journal-title":"Cancer"},{"key":"10.1016\/j.cllc.2019.08.004_bib18","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1097\/JTO.0b013e3182774108","article-title":"Computed tomography RECIST assessment of histopathologic response and prediction of survival in patients with resectable non-small-cell lung cancer after neoadjuvant chemotherapy","volume":"8","author":"William","year":"2013","journal-title":"J\u00a0Thorac Oncol"},{"key":"10.1016\/j.cllc.2019.08.004_bib19","doi-asserted-by":"crossref","first-page":"1753","DOI":"10.1200\/JCO.2006.07.3049","article-title":"Correlation of computed tomography and positron emission tomography in patients with metastatic gastrointestinal stromal tumor treated at a single institution with imatinib mesylate: proposal of new computed tomography response criteria","volume":"25","author":"Choi","year":"2007","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.cllc.2019.08.004_bib20","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1148\/radiol.12112428","article-title":"Non\u2013small cell lung cancer: histopathologic correlates for texture","volume":"266","author":"Ganeshan","year":"2013","journal-title":"Radiology"},{"key":"10.1016\/j.cllc.2019.08.004_bib21","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1007\/s00330-011-2319-8","article-title":"Tumour heterogeneity in non-small cell lung carcinoma assessed by CT texture analysis: a potential marker of survival","volume":"22","author":"Ganeshan","year":"2012","journal-title":"Eur Radiol"},{"key":"10.1016\/j.cllc.2019.08.004_bib22","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/j.cllc.2016.02.001","article-title":"Radiomic features are associated with EGFR mutation status in lung adenocarcinomas","volume":"17","author":"Liu","year":"2016","journal-title":"Clin Lung Cancer"},{"key":"10.1016\/j.cllc.2019.08.004_bib23","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.ejca.2017.10.017","article-title":"Patterns of responses in metastatic NSCLC during PD-1 or PDL-1 inhibitor therapy: comparison of RECIST 1.1, irRECIST and iRECIST criteria","volume":"88","author":"Tazdait","year":"2018","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.cllc.2019.08.004_bib25","doi-asserted-by":"crossref","first-page":"504","DOI":"10.6004\/jnccn.2017.0050","article-title":"Non-small cell lung cancer, Version 5.2017, NCCN clinical practice guidelines in oncology","volume":"15","author":"Ettinger","year":"2017","journal-title":"J\u00a0Natl Compr Canc Netw"},{"key":"10.1016\/j.cllc.2019.08.004_bib26","doi-asserted-by":"crossref","first-page":"3541","DOI":"10.1200\/JCO.2015.61.6870","article-title":"Pseudoprogression and immune-related response in solid tumors","volume":"33","author":"Chiou","year":"2015","journal-title":"J\u00a0Clin Oncol"}],"container-title":["Clinical Lung Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525730419302530?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525730419302530?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T19:10:29Z","timestamp":1761505829000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1525730419302530"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5]]},"references-count":25,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2020,5]]}},"alternative-id":["S1525730419302530"],"URL":"https:\/\/doi.org\/10.1016\/j.cllc.2019.08.004","relation":{},"ISSN":["1525-7304"],"issn-type":[{"value":"1525-7304","type":"print"}],"subject":[],"published":{"date-parts":[[2020,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"CT Volumetry and Basic Texture Analysis as Surrogate Markers in Advanced Non\u2013small-cell Lung Cancer","name":"articletitle","label":"Article Title"},{"value":"Clinical Lung Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cllc.2019.08.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}